 |
|
|
| |
Tolerability and antiviral activity of bictegravir/tenofovir
alafenamide/emtricitabine (Biktarvy) treatment switch
in patients aged 55 years or older with HIV: the BIO study
|
| |
| |
EACS 2021 Oct 27-30
R. Finlayson1, J. Carson2, L. Tan1
1Taylor Square Private Clinic, Clinical Research, Sydney, Australia, 2University of New South Wales, The Kirby Institute, Sydney, Australia
|
| |
|
|
|
|
|
